Does RIPRETINIB Cause Off label use? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Off label use have been filed in association with RIPRETINIB (QINLOCK). This represents 3.1% of all adverse event reports for RIPRETINIB.
137
Reports of Off label use with RIPRETINIB
3.1%
of all RIPRETINIB reports
11
Deaths
11
Hospitalizations
How Dangerous Is Off label use From RIPRETINIB?
Of the 137 reports, 11 (8.0%) resulted in death, 11 (8.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RIPRETINIB Alternatives Have Lower Off label use Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID